Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Glutathione in Parkinson's Disease
NCT02424708Phase 2Completed
- Sponsor
- Bastyr University
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glutathione in Parkinson's disease (PD), sponsored by Bastyr University. Started Apr 2015; status: completed.
02
Drugs
glutathione
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02424708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424708.